Tag - VRAX

Developments

Virax signs immune profiling product supply deal with Fosun

Virax Biolabs (NASDAQ: VRAX) has announced the signing of an exclusive commercial supply agreement with Fosun Diagnostics, a subsidiary of Fosun Pharma (600196.SS; 02196.HK), for its research-use-only ImmuneSelect...

July 13, 2026

Feature

Virax Biolabs readies clinical performance study of ViraxImmune Platform

Virax Biolabs (NASDAQ:VRAX) expects to begin in the third quarter a clinical performance study of its proprietary T-Cell testing platform, ViraxImmune, as a stepping stone for regulatory compliance in the U.S. and...

May 30, 2023

Tag - VRAX

Virax signs immune profiling product supply deal with Fosun

Virax Biolabs readies clinical performance study of ViraxImmune Platform

Subscribe